XML 54 R35.htm IDEA: XBRL DOCUMENT v3.24.0.1
Inventories, Net (Tables)
12 Months Ended
Dec. 31, 2023
Inventory Disclosure [Abstract]  
Schedule of Inventory, Current
The Company's net inventories consisted of the following as of December 31:
20232022
Raw materials$12,619,092 $12,899,659 
Consigned inventory149,701 168,923 
Finished goods, net of reserve4,645,098 4,322,167 
Total inventories17,413,891 17,390,748 
less non-current inventories(12,804,529)(7,527,167)
Total inventories classified as current$4,609,362 $9,863,581 
Schedule of Inventory, Noncurrent
The Company's non-current inventories consisted of the following as of December 31:
20232022
Vibativ - raw materials$6,611,426 $7,138,936 
Vibativ - finished goods810,454 — 
Kristalose - raw materials3,263,515 — 
Vaprisol - raw materials1,170,641 — 
Caldolor - finished goods67,307 — 
Sancuso - raw materials574,502 — 
Study drug - raw materials203,383 256,474 
Study drug - finished goods— 131,757 
Other products103,300 — 
Total non-current inventory$12,804,529 $7,527,167